$CRMD
CorMedix Inc. Stock $crmd

$crmd Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000121390024041031 Filed on May 09, 2024

Income Statement

Concept	2024 Q1	2023 Q1
Revenue
YoY Change
Cost Of Revenue	$818.5K
YoY Change
Gross Profit	-$818.5K
YoY Change
Gross Profit Margin
Selling, General & Admin	$15.05M	$7.610M
YoY Change	97.75%	60.17%
% of Gross Profit
Research & Development	$837.4K	$3.408M
YoY Change	-75.42%	48.96%
% of Gross Profit
Depreciation & Amortization	$21.83K	$16.86K
YoY Change	29.43%	-16.73%
% of Gross Profit
Operating Expenses	$15.89M	$11.02M
YoY Change	44.19%	56.53%
Operating Profit	-$16.70M	-$11.02M
YoY Change	51.62%	56.66%
Interest Expense	$9.835K	$8.776K
YoY Change	12.07%	-579.56%
% of Operating Profit
Other Income/Expense, Net	$843.3K	$450.0K
YoY Change	87.43%	-24647.35%
Pretax Income	-$15.86M	-$10.57M
YoY Change	50.1%	50.23%
Income Tax	-$1.395M
% Of Pretax Income
Net Earnings	-$14.47M	-$10.57M
YoY Change	36.9%	50.23%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.25	-$0.24
Diluted Earnings Per Share	-$0.25	-$0.24
COMMON SHARES
Basic Shares Outstanding	54.98M shares	44.50M shares
Diluted Shares Outstanding	57.50M shares	44.09M shares

Balance Sheet

Concept	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$58.55M	$55.60M
YoY Change	5.31%	-9.87%
Cash & Equivalents	$35.18M	$25.27M
Short-Term Investments	$23.37M	$30.33M
Other Short-Term Assets	$2.538M	$1.181M
YoY Change	114.96%	45.71%
Inventory	$2.320M
Prepaid Expenses	$295.8K	$2.910K
Receivables
Other Receivables
Total Short-Term Assets	$63.41M	$56.78M
YoY Change	11.67%	-9.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.906M	$1.608M
YoY Change	18.54%	-30.95%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$103.8K	$102.4K
YoY Change	1.46%	0.04%
Total Long-Term Assets	$4.614M	$2.452M
YoY Change	88.15%	0.9%
TOTAL ASSETS
Total Short-Term Assets	$63.41M	$56.78M
Total Long-Term Assets	$4.614M	$2.452M
Total Assets	$68.02M	$59.23M
YoY Change	14.84%	-8.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.826M	$1.447M
YoY Change	95.38%	-16.86%
Accrued Expenses	$6.553M	$3.089M
YoY Change	112.13%	20.95%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$9.534M	$4.675M
YoY Change	103.97%	8.85%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$476.6K	$631.4K
YoY Change	-24.52%	-18.0%
Total Long-Term Liabilities	$476.6K	$631.4K
YoY Change	-24.52%	-18.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.534M	$4.675M
Total Long-Term Liabilities	$476.6K	$631.4K
Total Liabilities	$10.01M	$5.306M
YoY Change	88.68%	4.77%
SHAREHOLDERS EQUITY
Retained Earnings	-$336.2M	-$285.9M
YoY Change	17.57%
Common Stock	$54.96K	$44.50K
YoY Change	23.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$58.01M	$53.93M
YoY Change
Total Liabilities & Shareholders Equity	$68.02M	$59.23M
YoY Change	14.84%	-8.78%

Cashflow Statement

Concept	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$14.47M	-$10.57M
YoY Change	36.9%	50.23%
Depreciation, Depletion And Amortization	$21.83K	$16.86K
YoY Change	29.43%	-16.73%
Cash From Operating Activities	-$17.31M	-$10.39M
YoY Change	66.54%	54.11%
INVESTING ACTIVITIES
Capital Expenditures	$61.31K	$14.77K
YoY Change	315.18%	-441.81%
Acquisitions
YoY Change
Other Investing Activities	$9.006M	-$14.67M
YoY Change	-161.38%	250.73%
Cash From Investing Activities	$8.945M	-$14.69M
YoY Change	-160.9%	250.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$97.12K	$7.200M
YoY Change	-101.35%	139.68%
NET CHANGE
Cash From Operating Activities	-$17.31M	-$10.39M
Cash From Investing Activities	$8.945M	-$14.69M
Cash From Financing Activities	-$97.12K	$7.200M
Net Change In Cash	-$8.463M	-$17.88M
YoY Change	-52.66%	125.51%
FREE CASH FLOW
Cash From Operating Activities	-$17.31M	-$10.39M
Capital Expenditures	$61.31K	$14.77K
Free Cash Flow	-$17.37M	-$10.41M
YoY Change	66.9%	54.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44090998	shares
CY2023Q1	us-gaap	Gross Profit GrossProfit		usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-34673
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	CORMEDIX INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-5894890
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	300 Connell Drive
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 4200
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Berkeley Heights
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07922
CY2024Q1	dei	City Area Code CityAreaCode	(908)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	517-9500
CY2024Q1	dei	Security12b Title Security12bTitle	Common stock, $0.001 par value
CY2024Q1	dei	Trading Symbol TradingSymbol	CRMD
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07922
CY2024Q1	dei	Trading Symbol TradingSymbol	CRMD
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	54959270	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35180529	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43642684	usd
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	75540	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	77453	usd
CY2024Q1	us-gaap	Short Term Investments ShortTermInvestments	23370989	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	32388130	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2320396	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2106345	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	295845	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	353574	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2166267	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	882214	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	63409566	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	79450400	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1905704	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1866224	usd
CY2024Q1	crmd	License Intangible Asset Non Current LicenseIntangibleAssetNonCurrent	2000000	usd
CY2024Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	103838	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	103055	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	604634	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	640278	usd
CY2024Q1	us-gaap	Assets Assets	68023742	usd
CY2023Q4	us-gaap	Assets Assets	82059957	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2826322	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4279679	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6553311	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6970217	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	154801	usd
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	54959270	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35180529	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43642684	usd
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	75540	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	77453	usd
CY2024Q1	us-gaap	Short Term Investments ShortTermInvestments	23370989	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	32388130	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2320396	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2106345	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	295845	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	353574	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2166267	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	882214	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	63409566	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	79450400	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1905704	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1866224	usd
CY2024Q1	crmd	License Intangible Asset Non Current LicenseIntangibleAssetNonCurrent	2000000	usd
CY2024Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	103838	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	103055	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	604634	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	640278	usd
CY2024Q1	us-gaap	Assets Assets	68023742	usd
CY2023Q4	us-gaap	Assets Assets	82059957	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2826322	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4279679	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6553311	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6970217	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	154801	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	150619	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	9534434	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11400515	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	476588	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	517013	usd
CY2024Q1	us-gaap	Liabilities Liabilities	10011022	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	181622	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	181622	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	181622	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	181622	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	182	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	182	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	160000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	160000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54959270	shares
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	150619	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	9534434	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11400515	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	476588	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	517013	usd
CY2024Q1	us-gaap	Liabilities Liabilities	10011022	usd
CY2023Q4	us-gaap	Liabilities Liabilities	11917528	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	181622	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	181622	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	181622	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	181622	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	182	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	182	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	160000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	160000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54959270	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54959270	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54938258	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54938258	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	54959	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	54938	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	83461	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	94108	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	394040254	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	391693214	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-336166136	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-321700013	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	58012720	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	70142429	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	68023742	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	82059957	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	818539	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	-818539	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	837445	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3407502	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15048252	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7609677	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-16704236	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-11017179	usd
CY2024Q1	us-gaap	Interest Income Other InterestIncomeOther	857186	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	446384	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4008	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	12345	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	8776	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	843343	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	449953	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15860893	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10567226	usd
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54959270	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	54959	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	54938	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	94108	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	394040254	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	391693214	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-336166136	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-321700013	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	58012720	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	70142429	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	68023742	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	82059957	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	837445	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3407502	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15048252	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7609677	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	15885697	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	11017179	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-16704236	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	446384	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4008	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	12345	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	9835	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	8776	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	843343	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	449953	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15860893	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10567226	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1394770	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-14466123	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10567226	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-10903	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	16393	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	256	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2096	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-10647	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	18489	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14476770	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10548737	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57503154	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44090998	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	70142429	usd
CY2024Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-97118	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2444179	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-10647	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-14466123	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	58012720	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	55059736	usd
CY2023Q1	crmd	Stock Issued In Connection With Atm Sale Of Common Stock Net StockIssuedInConnectionWithATMSaleOfCommonStockNet	7200406	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2216349	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	18489	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1394770	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-14466123	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10567226	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-10903	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	16393	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	256	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2096	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-10647	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	18489	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14476770	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10548737	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44090998	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	70142429	usd
CY2024Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-97118	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2444179	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-10647	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	58012720	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	55059736	usd
CY2023Q1	crmd	Stock Issued In Connection With Atm Sale Of Common Stock Net StockIssuedInConnectionWithATMSaleOfCommonStockNet	7200406	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2216349	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	18489	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10567226	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-14466123	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10567226	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2444179	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	35644	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	32582	usd
CY2024Q1	us-gaap	Depreciation Depreciation	21826	usd
CY2023Q1	us-gaap	Depreciation Depreciation	16863	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	214051	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1226454	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	419578	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1453352	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-755582	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-884872	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-36244	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-32422	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17310294	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10393886	usd
CY2024Q1	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	7693762	usd
CY2023Q1	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	25422039	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	16700000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	10750000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	61306	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14766	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	8944932	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14686805	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	97118	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7200406	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-97118	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-805	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2284	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10567226	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	53927754	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-14466123	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10567226	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2444179	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2216349	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	35644	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	32582	usd
CY2024Q1	us-gaap	Depreciation Depreciation	21826	usd
CY2023Q1	us-gaap	Depreciation Depreciation	16863	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	214051	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1226454	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	419578	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1453352	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-755582	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2415719	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-884872	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-36244	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-32422	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17310294	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10393886	usd
CY2024Q1	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	7693762	usd
CY2023Q1	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	25422039	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	16700000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	10750000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	61306	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14766	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	8944932	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14686805	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	97118	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7200406	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-97118	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7200406	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-805	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2284	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8463285	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-17878001	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43823192	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43374745	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35359907	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25496744	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	9835	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	8776	usd
CY2024Q1	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	2000000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	10903	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1525420	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	471415	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	580925	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	424572	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2320396	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2106345	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8463285	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43374745	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35359907	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25496744	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	9835	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	10903	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-16393	usd
CY2023	us-gaap	Investment Income Operating Tax Expense Benefit InvestmentIncomeOperatingTaxExpenseBenefit	1529000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	104400000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company bases its estimates and judgments on historical experience and various other assumptions that it believes are reasonable under the circumstances. The amounts of assets and liabilities and disclosure of contingent assets and liabilities in the Company’s consolidated balance sheets and the reported amounts of revenue and expenses reported for each of the periods presented are affected by estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates.</p>
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35180529	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25268225	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	179378	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	228519	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35359907	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25496744	usd
CY2023	us-gaap	Investment Income Operating Tax Expense Benefit InvestmentIncomeOperatingTaxExpenseBenefit	1529000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	104400000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company bases its estimates and judgments on historical experience and various other assumptions that it believes are reasonable under the circumstances. The amounts of assets and liabilities and disclosure of contingent assets and liabilities in the Company’s consolidated balance sheets and the reported amounts of revenue and expenses reported for each of the periods presented are affected by estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates.</p>
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Reclassifications</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain reclassifications were made to the prior year’s amounts to conform to the 2024 presentation.</p>
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35180529	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25268225	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	179378	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	228519	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35359907	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25496744	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	51716135	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2137	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	315	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	51714313	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	64920279	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1425	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	10506	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	64929360	usd
CY2024Q1	crmd	Inventories Expensed As Research And Development InventoriesExpensedAsResearchAndDevelopment	6388000	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	1424409	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	51716135	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2137	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	315	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	51714313	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	64920279	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1425	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	64929360	usd
CY2024Q1	crmd	Inventories Expensed As Research And Development InventoriesExpensedAsResearchAndDevelopment	6388000	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	1424409	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1525420	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	471415	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	580925	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	424572	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2320396	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2106345	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13811527	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11782480	shares
CY2024Q1	crmd	License Agreement Payable Current LicenseAgreementPayableCurrent	2000000	usd
CY2024Q1	crmd	Manufacturing Development Current ManufacturingDevelopmentCurrent	349421	usd
CY2023Q4	crmd	Manufacturing Development Current ManufacturingDevelopmentCurrent	1835101	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13811527	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11782480	shares
CY2024Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1340502	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2270022	usd
CY2024Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	2636726	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	2718770	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1340502	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2270022	usd
CY2024Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	2636726	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	2718770	usd
CY2024Q1	crmd	License Agreement Payable Current LicenseAgreementPayableCurrent	2000000	usd
CY2024Q1	crmd	Manufacturing Development Current ManufacturingDevelopmentCurrent	349421	usd
CY2023Q4	crmd	Manufacturing Development Current ManufacturingDevelopmentCurrent	1835101	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	226662	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	146324	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6553311	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6970217	usd
CY2024Q1	crmd	Amount Of Initial Licensing Fee AmountOfInitialLicensingFee	325000	usd
CY2024Q1	crmd	Shares Of Equity Of Common Stock SharesOfEquityOfCommonStock	7996	shares
CY2024Q1	crmd	Number Of Shares Released In Escrow NumberOfSharesReleasedInEscrow	7277	shares
CY2024Q1	crmd	Maximum Aggregate Amount Of Cash Payments Due Upon Achievement Of Milestones MaximumAggregateAmountOfCashPaymentsDueUponAchievementOfMilestones	3000000	usd
CY2024Q1	crmd	Balance Of Cash Payments Due Upon Achievement Of Milestones BalanceOfCashPaymentsDueUponAchievementOfMilestones	2000000	usd
CY2023	crmd	Balance Of Cash Payments Due Upon Achievement Of Milestones BalanceOfCashPaymentsDueUponAchievementOfMilestones	2000000	usd
CY2024Q1	crmd	Additional Amount Of Achievement Of Milestones AdditionalAmountOfAchievementOfMilestones	500000	usd
CY2024Q1	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	2000000	usd
CY2024Q1	crmd	License Agreement Payable Current LicenseAgreementPayableCurrent	2000000	usd
CY2023Q2	crmd	Purchase Of Additional Shares PurchaseOfAdditionalShares	1500093	shares
CY2024Q1	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	362000	usd
CY2023Q1	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	86000	usd
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	181622	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	181622	shares
CY2023Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	21291665	usd
CY2024Q1	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	21291665	usd
CY2024Q1	crmd	Shares Of Equity Of Common Stock SharesOfEquityOfCommonStock	7996	shares
CY2024Q1	crmd	Number Of Shares Released In Escrow NumberOfSharesReleasedInEscrow	7277	shares
CY2024Q1	crmd	Maximum Aggregate Amount Of Cash Payments Due Upon Achievement Of Milestones MaximumAggregateAmountOfCashPaymentsDueUponAchievementOfMilestones	3000000	usd
CY2024Q1	crmd	Balance Of Cash Payments Due Upon Achievement Of Milestones BalanceOfCashPaymentsDueUponAchievementOfMilestones	2000000	usd
CY2023	crmd	Balance Of Cash Payments Due Upon Achievement Of Milestones BalanceOfCashPaymentsDueUponAchievementOfMilestones	2000000	usd
CY2024Q1	crmd	Additional Amount Of Achievement Of Milestones AdditionalAmountOfAchievementOfMilestones	500000	usd
CY2024Q1	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	2000000	usd
CY2024Q1	crmd	License Agreement Payable Current LicenseAgreementPayableCurrent	2000000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	104000000	usd
CY2023Q2	crmd	Purchase Of Additional Shares PurchaseOfAdditionalShares	1500093	shares
CY2024Q1	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	362000	usd
CY2023Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	21291665	usd
CY2024Q1	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	21291665	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	52000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	155000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	477000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	668000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	151000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	517000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	605000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	640000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	51000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	50000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y7M6D
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y7M6D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.09	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.09	pure
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	154000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	208000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	211000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	169000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	742000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	110000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	632000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	crmd	License Intangible Asset Non Current LicenseIntangibleAssetNonCurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Revenues Revenues		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57503154	shares
CY2024Q1	crmd	Cancellation Of Shares Held In Escrow CancellationOfSharesHeldInEscrow		usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation		usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y7M6D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2020Q3	us-gaap	Payments For Leasing Costs PaymentsForLeasingCosts	17000	usd
CY2024Q1	crmd	Rental Agreement Expense RentalAgreementExpense	400	eur
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	52000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	52000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	632000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	155000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	477000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	668000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	151000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	517000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	605000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	640000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	51000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	50000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y7M6D
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y7M6D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.09	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.09	pure
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	154000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	208000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	169000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	742000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	110000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	632000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	crmd	License Intangible Asset Non Current LicenseIntangibleAssetNonCurrent		usd
CY2024Q1	us-gaap	Revenues Revenues		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57503154	shares
CY2024Q1	crmd	Cancellation Of Shares Held In Escrow CancellationOfSharesHeldInEscrow		usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation		usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods		usd
CY2023Q4	crmd	License Agreement Payable Current LicenseAgreementPayableCurrent		usd
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001410098
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods		usd
CY2023Q4	crmd	License Agreement Payable Current LicenseAgreementPayableCurrent		usd
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001410098

Files In Submission

Name	View Source	Status
0001213900-24-041031-index-headers.html	Edgar Link	pending
0001213900-24-041031-index.html	Edgar Link	pending
0001213900-24-041031.txt	Edgar Link	pending
0001213900-24-041031-xbrl.zip	Edgar Link	pending
crmd-20240331.xsd	Edgar Link	pending
ea0205096-10q_cormedix.htm	Edgar Link	pending
ea020509601ex31-1_cormedix.htm	Edgar Link	pending
ea020509601ex31-2_cormedix.htm	Edgar Link	pending
ea020509601ex32-1_cormedix.htm	Edgar Link	pending
ea020509601ex32-2_cormedix.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
crmd-20240331_cal.xml	Edgar Link	unprocessable
crmd-20240331_def.xml	Edgar Link	unprocessable
crmd-20240331_lab.xml	Edgar Link	unprocessable
crmd-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0205096-10q_cormedix_htm.xml	Edgar Link	completed
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRMD
CorMedix Inc. Stock $crmd

2024 Q1 Form 10-Q Financial Statement

#000121390024041031 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRMD CorMedix Inc. Stock $crmd

2024 Q1 Form 10-Q Financial Statement

#000121390024041031 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRMD
CorMedix Inc. Stock $crmd